1 |
Insulin and analogues |
Regular insulin |
Hypoglycemia, weight gain, insulin allergy, and lipodystrophy at injection sites |
2 |
Sulphonylureas |
Glibenclamide |
Hypoglycemia, weight gain, cardiovascular risk, rash, cholestatic jaundice, bone marrow damage, and photosensitivity |
3 |
Meglitinides |
Repaglinide |
Hypoglycemia and sensitivity reactions |
4 |
Biguanides |
Metformin |
Gastrointestinal effects and lactic acidosis |
5 |
GLP-1 agonists |
Exenatide |
Gastrointestinal effects, pancreatitis risks for cancer, and cardiovascular events |
6 |
DPP-4 inhibitors |
Saxagliptin |
Pancreatitis, risk for cancer, acute hepatitis, and kidney impairment |
7 |
Thiazolidinediones |
Pioglitazone |
Hepatitis, cardiovascular risk, bladder cancer, water retention, and weight gain |
8 |
Dual PPAR agonists |
Saroglitazar |
Gastritis, asthenia, and pyrexia |
9 |
Alpha-glucosidase inhibitors |
Acarbose |
Gastrointestinal effects and hepatitis |
10 |
Amylin analogues |
Pramlintide |
Hypoglycemia and allergy |
11 |
SGLT 2 inhibitors |
Canagliflozin |
Glycosuria and cardiovascular concern |